1443138-53-1
|
|
- CAS号:
- 1443138-53-1
- 英文名:
- gsk2200150a
- 英文别名:
- GSK220150A;gsk2200150a;inhibit,Inhibitor,GSK2200150A,GSK-2200150A,Bacterial;1-[(2,3-Dihydro-1,4-benzodioxin-6-yl)methyl]-6',7'-dihydro-spiro[piperidine-4,4'-[4H]thieno[3,2-c]pyran];Spiro[piperidine-4,4'-[4H]thieno[3,2-c]pyran], 1-[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]-6',7'-dihydro-
- 中文名:
- 1443138-53-1
- 中文别名:
- 化合物GSK2200150A
- CBNumber:
- CB24656560
- 分子式:
- C20H23NO3S
- 分子量:
- 357.47
- MOL File:
- 1443138-53-1.mol
|
|
|
1443138-53-1化学性质
-
沸点:
-
503.4±50.0 °C(Predicted)
-
|
-
密度:
-
1.31±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO:68.0(Max Conc. mg/mL);190.23(Max Conc. mM)
Ethanol:18.0(Max Conc. mg/mL);50.35(Max Conc. mM)-
|
-
酸度系数(pKa):
-
8.39±0.20(Predicted)
-
|
1443138-53-1性质、用途与生产工艺
GSK2200150A 是通过高通量表型筛选确定的一种抗结核剂。对 H37Rv 的 MIC 是 0.38 μM。
MIC: 0.38 μM (
M.tuberculosis
strain H37Rv)
GSK2200150A is a novel antimycobacterial agent against
Mycobacterium tuberculosis
.The activities of GSK2200150A containing the spirocycle core are determined against the virulent
M.tuberculosis
strain (H37Rv) with MIC of 0.38 μM.
1443138-53-1
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/01/25 | HY-112091 | 1443138-53-1 GSK2200150A | 1443138-53-1 | 5mg | 680元 |
2024/01/25 | HY-112091 | 1443138-53-1 GSK2200150A | 1443138-53-1 | 10mM * 1mLin DMSO | 748元 |
1443138-53-1, 1443138-53-1 相关搜索:
- 化合物GSK2200150A
- 1443138-53-1
- Spiro[piperidine-4,4'-[4H]thieno[3,2-c]pyran], 1-[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]-6',7'-dihydro-
- inhibit,Inhibitor,GSK2200150A,GSK-2200150A,Bacterial
- 1-[(2,3-Dihydro-1,4-benzodioxin-6-yl)methyl]-6',7'-dihydro-spiro[piperidine-4,4'-[4H]thieno[3,2-c]pyran]
- GSK220150A
- gsk2200150a